Innovation Center of NanoMedicne, Kawasaki Institute of Industrial Promotion, 3-25-14 Tonomachi, Kawasaki-ku, Kawasaki 210-0821, Japan.
Institute for Future Initiatives, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
J Am Chem Soc. 2021 Jan 20;143(2):538-559. doi: 10.1021/jacs.0c09029. Epub 2020 Dec 28.
The past few decades have witnessed an evolution of nanomedicine from biologically inert entities to more smart systems, aimed at advancing functionality. However, we should recognize that most systems still rely on reasonable explanation-including some over-explanation-rather than definitive evidence, which is a watershed radically determining the speed and extent of advancing nanomedicine. Probing nano-bio interactions and desirable functionality at the tissue, cellular, and molecular levels is most frequently overlooked. Progress toward answering these questions will provide instructive insight guiding more effective chemo-physical strategies. Thus, in the next generation, we argue that much effort should be made to provide definitive evidence for proof-of-, in lieu of creating many new and complicated systems for similar proof-of-.
在过去的几十年中,纳米医学已经从生物惰性实体演变为更智能的系统,旨在提高功能。然而,我们应该认识到,大多数系统仍然依赖于合理的解释——包括一些过度解释——而不是明确的证据,这是一个分水岭,从根本上决定了纳米医学的发展速度和程度。在组织、细胞和分子水平上探测纳米-生物相互作用和理想的功能往往被忽视。朝着回答这些问题的方向取得进展将为指导更有效的化学-物理策略提供有益的见解。因此,在下一个阶段,我们认为应该做出很大的努力,为证实——而不是为类似的证实创造许多新的和复杂的系统——提供明确的证据。